SCHEMBL6428670

SCHEMBL6428670

COc1c(C(=O)NCCc2cccnc2)ccc2[nH]nc(/C=C/c3ccc(F)cc3)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.46
KCNK3 O14649 1/20 0.43
KCNH2 Q12809 1/20 0.43
NAMPT P43490 1/20 0.41
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
THRB P10828 1/20 0.39
KMT2A Q03164 2/20 0.38
TLR7 Q9NYK1 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PTAFR P25105 2/20 0.38
MEN1 O00255 1/20 0.38
PKM P14618 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428413 0.92 THRB (0.46) THRBKMT2ASMN1; SMN2MEN1PKM
SCHEMBL6428652 0.90 SMN1; SMN2 (0.44) NAMPTHDAC2HDAC8HDAC6SMN1; SMN2
SCHEMBL6426371 0.85 RAB9A (0.42) NAMPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL13927780 0.84 THRB (0.55) THRBKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL4148832 0.84 TP53 (0.46) AURKATHRBKMT2ASMN1; SMN2KDM4E
SCHEMBL4148835 0.84 TP53 (0.46) AURKATHRBKMT2ASMN1; SMN2KDM4E
SCHEMBL6427073 0.83 RECQL (0.46) THRBKMT2AKDM4EALDH1A1POLB
SCHEMBL6428532 0.83 POLB (0.47) THRBKMT2ASMN1; SMN2KDM4EPOLB
SCHEMBL6426257 0.83 BRD4 (0.44) AURKASMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4152203 0.83 MAPT (0.45) THRBKMT2ASMN1; SMN2KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B AURKA 710/4885KCNK3 715/4885KCNH2 979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.